The brainchild of Dhaval Shah and Dharmil Sheth from Mumbai, PharmEasy has emerged as a leader in the online pharmacy space since its launch in 2015 for a reason: India’s drug distribution system is disorganised, lacking established retail chains, and forcing pharmacies to depend on middlemen. PharmEasy supplies medicines to customers at a flat 20 percent discount. In 2019, PharmEasy merged with its investor entity, Ascent Health, to form API Holdings. This June, PharmEasy’s takeover of Thyrocare helped it double its valuation to ₹30,000 crore, and strengthen its position in the diagnostics industry.